Cargando…
SARS-CoV-2 cell entry beyond the ACE2 receptor
BACKGROUND: Angiotensin-converting enzyme 2 (ACE2) is known as the major viral entry site for SARS-CoV-2. However, viral tissue tropism and high rate of infectivity do not directly correspond with the level of ACE2 expression in the organs. It may suggest involvement of other receptors or accessory...
Autores principales: | Alipoor, Shamila D., Mirsaeidi, Mehdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244107/ https://www.ncbi.nlm.nih.gov/pubmed/35754059 http://dx.doi.org/10.1007/s11033-022-07700-x |
Ejemplares similares
-
Inborn Errors in the LRR Domain of Nod2 and Their Potential Consequences on the Function of the Receptor
por: Alipoor, Shamila D., et al.
Publicado: (2021) -
ACE2: The Major Cell Entry Receptor for SARS-CoV-2
por: Scialo, Filippo, et al.
Publicado: (2020) -
Human ACE2 Genetic Polymorphism Affecting SARS-CoV and SARS-CoV-2 Entry into Cells
por: Hattori, Takanari, et al.
Publicado: (2022) -
ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
por: Zamorano Cuervo, Natalia, et al.
Publicado: (2020) -
MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes
por: Lu, Dongchao, et al.
Publicado: (2020)